The Journal of Practical Medicine >

2025 , Vol. 41 >Issue 17: 2617 - 2623

DOI: https://doi.org/10.3969/j.issn.1006-5725.2025.17.002

Feature Reports： Myocardial Damage

Effect of Ad⁃HIF⁃1α⁃Trip on apoptosis of H9c2 cardiomyocytes under high glucose and hypoxic conditions

  • Li MAI ,
  • Yongting PAN ,
  • Wenkai HE ,
  • Xiaoqian WU ,
  • Mingyan LI
Expand
  • Department of Cardiology，the Second Affiliated Hospital of Guangzhou Medical University，Guangzhou 511400，Guangdong，China

Received date: 2025-04-03

  Online published: 2025-09-05

Fold

Abstract

Objective To investigate the effect of the mutant of adenovirus?mediated HIF?1α triple mutant (Ad?HIF?1α?Trip) on the apoptosis of H9c2 cardiomyocytes under high glucose and hypoxia conditions. Methods H9c2 cardiomyocytes were cultured under hypoxic conditions in vitro and randomly divided into four groups based on glucose concentration and viral transfection status： low oxygen + normal glucose concentration group （LO + NG group）， low oxygen + high glucose concentration group （LO + HG group）， low oxygen+high glucose + adenoviral null vector group （LO + HG + Ad?Null group）， and low oxygen+high glucose + adenovirus HIF?1α triple mutant group （LO + HG + Ad?HIF?1α?Trip group）. After 12 hours of hypoxia， HIF?1α， PI3K， and Akt expression were measured via qRT?PCR and Western blot， and apoptosis of H9c2 cardiomyocytes was assessed by flow cytometry. Results HIF?1α， PI3K， and Akt expression decreased in cardiomyocytes under high glucose and hypoxia， while Ad?HIF?1α?Trip enhanced their expression. Flow cytometry revealed increased apoptosis under high glucose and hypoxia， which was reduced by Ad?HIF?1α?Trip. Conclusion Ad?HIF?1α?Trip upregulates HIF?1α， PI3K， and Akt in H9c2 cardiomyocytes under high glucose and hypoxia， likely reducing apoptosis via PI3K?Akt pathway activation.

Key words： Ad?HIF?1α?Trip; adenovirus; PI3K?Akt signaling pathway; cardiomyocyte apoptosis; diabetes; diabetic cardiomyopathy

Cite this article

Li MAI , Yongting PAN , Wenkai HE , Xiaoqian WU , Mingyan LI . Effect of Ad⁃HIF⁃1α⁃Trip on apoptosis of H9c2 cardiomyocytes under high glucose and hypoxic conditions[J]. The Journal of Practical Medicine, 2025 , 41(17) : 2617 -2623 . DOI: 10.3969/j.issn.1006-5725.2025.17.002

References

[1] CATRINA S B， ZHENG X. Hypoxia and hypoxia - inducible factors in diabetes and its complications［J］. Diabetologia， 2021， 64（4）：709-716. doi:10.1007/s00125-021-05380-z
[2] MA L， WANG J， ZHOU R， et al. Traditional Chinese Medicine-derived formulations and extracts modulating the PI3K/AKT pathway in Alzheimer's disease［J］. Front Pharmacol， 2025， 16： 1528919. doi:10.3389/fphar.2025.1528919
[3] LI R， CHEN Y， LIU G， et al. PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers［J］. Cell Death Dis， 2020， 11（9）： 1-12. doi:10.1038/s41419-020-02998-6
[4] SONG H P， CHU Z G， ZHANG D X， et al. PI3K-AKT pathway protects cardiomyocytes against hypoxia-induced apoptosis by MitoKATP-mediated mitochondrial translocation of pAKT［J］. Cell Physiol Biochem， 2018， 49（2）： 717-727. doi:10.1159/000493037
[5] ZHANG Q H， LI Y M， ZHANG D J. Hypoxia-inducible factor and coronary heart disease： Antagonism and protection［J］. J Clin Rehabil Tissue Engineer Res， 2021， 25（35）： 5729-5734.
[6] ZHANG Z， YAO L， YANG J， et al. PI3K/Akt and HIF-1 signaling pathway in hypoxia-ischemia （Review）［J］. Molecul Med Rep， 2018， 18（4）： 3547-3554.
[7] AGHAEI-ZARCH S M. Crosstalk between MiRNAs/lncRNAs and PI3K/AKT signaling pathway in diabetes mellitus： Mechanistic and therapeutic perspectives［J］. Non-coding RNA Res， 2024， 9（1）： 1-12. doi:10.1016/j.ncrna.2024.01.005
[8] HUANG X， LIU G， GUO J， et al. The PI3K/AKT pathway in obesity and type 2 diabetes［J］. Int J Biol Sci， 2018， 14（11）： 1483-1496. doi:10.7150/ijbs.27173
[9] LI M， LIU C， BIN J， et al. Mutant hypoxia inducible factor-1α improves angiogenesis and tissue perfusion in ischemic rabbit skeletal muscle［J］. Microvascul Res， 2011， 81（1）： 26-33. doi:10.1016/j.mvr.2010.09.008
[10] XIE J， LIAO Y， YANG L， et al. Ultrasound molecular imaging of angiogenesis induced by mutant forms of hypoxia-inducible factor-1α［J］. Cardiovasc Res， 2011， 92（2）：256-266. doi:10.1093/cvr/cvr229
[11] MURTAZA G， VIRK H U H， KHALID M， et al. Diabetic cardiomyopathy—A comprehensive updated review［J］. Progress Cardiovasc Dis， 2019， 62（4）： 315-326. doi:10.1016/j.pcad.2019.03.003
[12] 成扶雨， 余琪琪， 袁伟. NADPH氧化酶在糖尿病心血管并发症中的研究进展［J］. 实用医学杂志， 2019， 35（14）：2342- 2346.
[13] GALEONE A， ANNICCHIARICO A， BUCCOLIERO C， et al. Diabetic Cardiomyopathy： Role of Cell Death， Exosomes， Fibrosis and Epicardial Adipose Tissue［J］. Int J Mol Sci， 2024， 25（17）：9481. doi:10.3390/ijms25179481
[14] PAN K L， HSU Y C， CHANG S T， et al. The Role of Cardiac Fibrosis in Diabetic Cardiomyopathy： From Pathophysiology to Clinical Diagnostic Tools［J］. Int J Mol Sci， 2023， 24（10）：8604. doi:10.3390/ijms24108604
[15] YA-WEN DENG F L， ZHI-TONG LI， GAO JING-HAN， et al. Correction to： Hyperglycemia promotes myocardial dysfunction via the ERS-MAPK10 signaling pathway in db/db mice［J］. Lab Invest， 2022， 102（10）：1163-1165. doi:10.1038/s41374-022-00833-4
[16] GOGIRAJU R， BOCHENEK M L， SCH?FER K. Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure［J］. Front Cardiovasc Med， 2019， 6：20. doi:10.3389/fcvm.2019.00020
[17] 夏夏， 夏中元. 稳定缺氧诱导因子-1α表达对1型糖尿病心肌缺血再灌注损伤大鼠心肌细胞线粒体自噬的影响［J］. 中华实用诊断与治疗杂志， 2020， 34（10）： 978-981.
[18] DE J A C， HSIANG C A， HOSSEIN. Metabolic Suppression of HIF-1α Contributes to Susceptibility of Ischemic Injury in Diabetic Hearts［J］. JACC Basic Transl Sci， 2018， 3（4）：499-502. doi:10.1016/j.jacbts.2018.07.001
[19] 钟祯， 李万根， 张霄旦. 高糖诱导 H9c2 心肌细胞TRAP1的表达变化及意义［J］. 实用医学杂志， 2018， 34（24）：4022-4026.
[20] 王雪梅，刘芬，曹莹，等. HIF-1α介导线粒体功能调控糖尿病心肌缺血再灌注损伤的作用机制研究［J］. 心血管病学进展，2020，41（10）：1085-1090+1095.
[21] MICHAEL S D M D， CLAUDIA N M， MATTHEW K， et al. Fatty Acids Prevent Hypoxia-Inducible Factor-1α Signaling Through Decreased Succinate in Diabetes［J］. JACC Basic Transl Sci， 2018， 3（4）：485-498. doi:10.1016/j.jacbts.2018.04.005
[22] BESS S N， IGOE M J， DENISON A C， et al. Autofluorescence imaging of endogenous metabolic cofactors in response to cytokine stimulation of classically activated macrophages［J］. Cancer Metab， 2023， 11（1）：22. doi:10.1186/s40170-023-00325-z
[23] EZEANI M， PRABHU S. PI3K （p110α） as a determinant and gene therapy for atrial enlargement in atrial fibrillation［J］. Mol Cell Biochem， 2022， 478（3）：471-490. doi:10.1007/s11010-022-04526-w
[24] 张家伟，许莉莉，吕佩源. PI3K/AKT信号通路与缺血性脑损伤引起的细胞凋亡研究进展［J］. 临床与病理杂志，2022，42（11）：2826-2831.
[25] ZHANG Z L Y， YANG J， WANG Z， et al. PI3K/Akt and HIF-1 signaling pathway in hypoxia - ischemia （Review）［J］. Mol Med Rep， 2018， 81（1）：26-33.
[26] ZHANG L Q Y， YANG C， TANG J， et al. Signaling pathway involved in hypoxia-inducible factor-1α regulation in hypoxic-ischemic cortical neurons in vitro［J］. Neurosci Lett， 2009， 461（1）：1-6. doi:10.1016/j.neulet.2009.03.091
[27] AGHAEI-ZARCH S M. Crosstalk between MiRNAs/lncRNAs and PI3K/AKT signaling pathway in diabetes mellitus： Mechanistic and therapeutic perspectives［J］. Non - coding RNA Res， 2024， 9（2）：486-507. doi:10.1016/j.ncrna.2024.01.005
[28] WALKOWSKI B， KLEIBERT M， MAJKA M， et al. Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart［J］. Cells， 2022， 11（9）：1553. doi:10.3390/cells11091553
Options
Outlines

/

〈 〉